Workflow
NeuroSense Therapeutics(NRSN) - 2025 Q2 - Quarterly Report

| | June 30, | December 31, | | --- | --- | --- | | | 2025 | 2024 | | Assets | | | | Current assets: | | | | Cash and cash equivalent | 666 | 3,378 | | Other receivables | 847 | 989 | | Restricted deposit | 43 | 35 | | Total current assets | 1,556 | 4,402 | | Non-current assets: | | | | Property, plant and equipment, net | 63 | 66 | | Operating right of use assets | 42 | 84 | | Restricted deposit | 23 | 23 | | Total non-current assets | 128 | 173 | | Total assets | 1,684 | 4,575 | | Liabilities and Equity | ...